Accéder au contenu principal

Accès membres

Menu principal

Accueil
Avis de la SFPT
Congrès 2025
Groupes de travail
Vie de la SFPT / Adhésion
Journaux
- Fundamental Clinical Pharmacology
- Therapies
Docamed-SFPT

Accès membres

Accueil
Avis de la SFPT
Congrès 2025
Groupes de travail
Vie de la SFPT / Adhésion
Journaux
- Fundamental Clinical Pharmacology
- Therapies
Docamed-SFPT

Publié dans FCP.

FCP- Numéro Avril 2024

Voici le numéro FCP Avril 2024.

Bonne lecture!

Dernière mise à jour le 22 mars 2024.

Rédacteurs en chef
Luc ZIMMER

Site web du journal (Wiley)
Twitter @FCP_SFPT

Editorial Board
Soumission électronique
Articles sur EarlyView
Tous les numéros de FCP

Dernières publications

Wiley: Fundamental & Clinical Pharmacology: Table of Contents

Repurposing bosentan as an anticancer agent: EGFR/ERK/c‐Jun modulation inhibits NSCLC tumor growth
Fluoxetine‐induced downregulation of circMap2k1 signaling cascade to improve neurological function after ischemic stroke
The synergy between alkylating agents and ERCC1–XPF inhibitors is p53 dependent
Fundamental and Clinical Pharmacology of drug repositioning
Breastfeeding and contrast agents—A critical review and presentation of new aspects
Capivasertib augments chemotherapy via Akt inhibition in preclinical small cell lung cancer models
New ways to repurpose salmeterol in an animal model of fibromyalgia
Induction of Ca2+ signaling and cytotoxic responses of human lung fibroblasts upon an antihistamine drug oxatomide treatment and evaluating the protective effects of Ca2+ chelating
Body mass index affects imatinib exposure: Real‐world evidence from TDM with adaptive dosing
Knockdown of RFC3 enhances the sensitivity of colon cancer cells to oxaliplatin by inducing ferroptosis

Conception Internet Bordeaux - Webmaster Vincent RICHARD